JB Pharma records revenue growth of 36% to INR 809 crores in Q2 FY23
Operating EBITDA* grew by 44% to INR 202 crores Mumbai, India; November 12, 2022 –…
Operating EBITDA* grew by 44% to INR 202 crores Mumbai, India; November 12, 2022 –…
Delhi /NCR’s biggest thematic property was started in 2018 and their first outlet was launched…
Goa, November 2022: Make a Difference (MAD), a leading NGO that works for children in…